Nursing care in preterm infants with Patent Ductus Arteriosus
Keywords:
Patent Ductus Arteriosus, preterm, nursing careAbstract
In preterm, failure or delay in spontaneous closure of Ductus Arteriosus (DA), resulting in the condition of Patent Ductus Arteriosus (PDA), blood from the Aorta flow to the Pulmonary artery to the lung. A prolonged situation of PDA can be associated with several short- and long-term complications in preterm such as pulmonary edema, pulmonary hemorrhage, and chronic lung disease. Prophylaxis and treatment are necessary for PDA closure. The first-line therapy is an oral medical treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, ibuprofen, and paracetamol with low to high side effects such as abdominal distension, necrotizing enterocolitis (NEC), and acute renal failure. The second-line therapy is operation including clipping PDA and PDA ligation in case of failure of medical treatment. Nurses should play important roles to care for preterm. Nurses can earlier detect signs and symptoms of PDA, provide an accurate dosage of medicine, monitor post-operation care, prevent complications for efficacy, and higher safety for PDA closure in preterm.
I
References
Benitz WE and Committee on Fetus and Newborn. Patent Ductus Arteriosus in Preterm Infants. Pediatrics. 2016;137(1):1-6.
Prangwatanagul W. Outcome and Complication Rates of PDA Clipping and Ibuprofen/Indomethacin in the Neonates at Prapokklao Hospital. The Journal of Prapokklao Hospital Clinical Medical Education Center. 2020;37(1):16-25.
Hamrick SEG, Hansmann G, Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125(5):1020-30.
Dollberg S, Lusky A, Reichman B, Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol /Nutr. 2005;40(2):184-8.
Bennett PS, Angela JS. Nursing Assessment, Education and Care of Extremely Preterm Neonates with Patent Ductus Arteriosus. Curr Pediatr Rev. 2016;12(2):106-8.
Lakshminrusimha S, Saugstad OD. The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy. J Perinatol. 2016;36:S3–S11.
DiMenna L, Laabs C, McCoskey L, Seals A. Management of the neonate with patent ductus arteriosus. J Perinat Neonat Nurs. 2006;20(4):333-40.
Zipes DP, Libby P, Bonow RO and Braunwald E. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. W.B Ssunders: St.Louis; 2007.
Syamasundar PR. Percutaneous Closure of Patent Ductus Arteriosus: State of the Art. J Invasive Cardiol. 2007;19(7):1-13.
Jennifer LS, Shahab N. What is a hemodynamically significant PDA in preterm infants? CHD. 2019; 14:21-6.
Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not close: the very small patent ductus arteriosus. CHD. 2010;5:354-65.
Vettukattil JJ. Patent ductus arteriosus in extremely premature neonates. Curr Pediatr Rev. 2016;12(2):78-82.
Mitra S, Florez ID, Tamayo ME, Aune D, Mbuagbaw L, Veroniki AA, Thabane L. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis. BMJ Open. 2016 Jul 25;6(7):e011271. doi: 10.1136/bmjopen-2016-011271. PMID: 27456327; PMCID: PMC4964163.
Demir N, Peker E, Ece I, Balahoroglu R, Tuncer O. Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants. J.Matern-Fetal Neonatal Med. 2017;30(17):2119-25.
Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: A surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128(6):e1618-21.
Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1252-8. PMID: 12549803.
Galal MO, Hussain A, Arfi A. Dowe still need the surgeon to close the persistently patent arterial duct? Cardiol Young. 2006; 16:522-36.
Butera G, De Rosa G, Chessa M, Piazza L, Delogu A, Frigiola A, et al. Transcatheter closure of the persistent arterial duct with the Amplatzer duct ocludder in very young symptomatic children. Heart. 2004;90:1467-70.
Samuel BP, Stuive AJ, Eding DM. Nursing Assessment Education and Care of Extremely Premature Neonates with Patent Ductus Arteriosus. Curr Pediatr Rev.2016;12(1):106-9.
Pourarian S, Sharma D, Farahbakhsh N, Cheriki S, Bijanzadeh F. To evaluate the prevalence of symptomatic and non-symptomatic ductus arteriosus and accuracy of physical signs in diagnosing PDA in preterm infants using blinded comparison of clinical and echocardiographic findings during the first week of life: a prospective observational study from Iran.J Matern Fetal Neonatal Med. 2017;30(14):1666-70.
Vega-Barrera C, Muraskas J, Guo R, Ray B. The pulse pressure in a premature infant less than 37 weeks gestational age with a patent ductus arteriosus. J Pediatr. 2013;3(1):99-104.
El-Sayed NY, Fraser D. Patent Ductus Arteriosus in Preterm Infants, Part 1: Understanding the Pathophysiologic Link Between the Patent Ductus Arteriosus and Clinical Complications. NN. 2017;36(5):265-71.
Lin PW, Stoll BJ. Necrotizing enterocolitis. Lancet. 2006; 368:1271-83.
Bradbury AW, Brittenden J, McBride K, Rukley CV. Mesenteric ischemia: a multidisciplinary approach. Br J Surg. 1995; 82:1446-59.
Selimer A, Lene HT, Johansen A, Henriksen TB. Necrotizing enterocolitis after red blood cell transfusion in preterm infants with patent ductus arteriosus: a case series. Int J Paediatr. 2012;101:570-2.
Garo D, Andersen SK, Partridge JC, et al. Diminished white matter injury over time in a cohort of premature newborns. J Pediatr. 2015;166(1):39-43.
Gregory KE. Pharmacologic treatment of Patent Ductus Arteriosus in the preterm Infant. J Perinat Neonatal Nurs. 2016 Jan-Mar;30(1):6-8. doi: 10.1097 /JPN.0000000000000157. PMID: 26813387.
Neu J. Gastrointestinal development and meeting the nutritional needs of premature infants. Am J Clin Nutr. 2007 Feb;85(2):629S-634S. doi: 10.1093/ajcn/85.2. 629S. PMID: 17284768.
Heiman H, Schanler RJ. Enteral nutrition for premature infants: the role of human milk. Semin Fetal Neonatal Med. 2007; 12:26-34.
Sauret A, Andro-Garcon MC, Chauvel J, Ligneul A, Dupas P, et al. Osmolality of a fortified human preterm milk: The effect of fortifier dosage, gestational age, lactation stage, and hospital practices. Arch Pediatr. 2018;25(7):411-15.
Neumann R, Schulzke SM, Buhrer C. Oral ibuphofen vesus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology. 2012;102:9-15.
El-Khuffash AF, Jain A, McNamara PJ. Ligation of the patent ductus arteriosus in preterm infants: understanding the physiology. J Pediatr. 2013 Jun;162(6):1100-6. doi: 10.1016/j.jpeds.2012.12.094. Epub 2013 Feb 11. PMID: 23410600.
Mandhan P, Brown S, Kukkady A, Samarakkody U. Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis. 2009 Jan-Feb;4(1):34-7. doi: 10.1111/j.1747-0803.2008.00241. x. PMID: 19207401.
Szymankiewicz M, Hodgman JE, Siassi B, Gadzinowski J. Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonate. 2004; 85:32-6.
Jain A, Sahni M, El-Khuffash A, Khadawardi E, Sehgal A, McNamara PJ. Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation. J Pediatr. 2012;160:584-9.e581
Suraseranivongse S, Kaosaard R, Intakong P, et al. A comparison of postoperative pain scales in neonates. Br J Anaesth. 2006;97(4):540-4.
Busse M, Stromgren K, Thomgate L, Thomas KA. Parent responses to stress: PROMS in the NICU. Crit Care Nurse. 2013;33(4):52-60.
Linda S, Trudi M. Identification of parental stressors in an Australian neonatal intensive care unit. Neonatal, Paediatr. Child Health Nurs. 2012;15(2):8-16.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Thai Journal of Cardio-Thoracic Nursing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความนี้ยังไม่เคยตีพิมพ์หรืออยู่ในระหว่างส่งไปตีพิมพ์ในวารสารอื่น ๆ มาก่อน และกองบรรณาธิการขอสงวนสิทธิ์ในการตรวจทาน และแก้ไขต้นฉบับตามเกณฑ์ของวารสาร ในกรณีที่เรื่องของท่านได้ได้รับการตีพิมพ์ในวารสารฉบับนี้ถือว่าเป็น ลิขสิทธิ์ของวารสารพยาบาลโรคหัวใจและทรวงอก
